Filtros de búsqueda

Lista de obras de

A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma

artículo científico publicado en 2014

A pan-cancer proteomic perspective on The Cancer Genome Atlas.

artículo científico publicado en 2014

AXL inhibition induces DNA damage and replication stress in non-small cell lung cancer cells and promotes sensitivity to ATR inhibitors

artículo científico publicado en 2020

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

artículo científico publicado en 2016

Blasted cell line names

artículo científico publicado en 2010

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

artículo científico publicado en 2017

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities

artículo científico publicado en 2015

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion

scientific article published on 09 September 2020

DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy

artículo científico publicado en 2011

Dual inhibition of MEK and AXL targets tumor cell heterogeneity and prevents resistant outgrowth mediated by the epithelial-to-mesenchymal transition in NSCLC

artículo científico publicado en 2021

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

artículo científico publicado en 2012

Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus

artículo científico publicado en 2012

Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition

artículo científico publicado en 2014

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.

artículo científico publicado en 2014

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

artículo científico publicado en 2014

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

artículo científico publicado en 2021

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

artículo científico publicado en 2020

Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation

artículo científico publicado en 2010

Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?

artículo científico publicado en 2019

The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

artículo científico publicado en 2020

The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA

artículo científico publicado en 2012

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

artículo científico publicado en 2002